Janus Henderson Group
FATE icon

Janus Henderson Group’s Fate Therapeutics FATE Stock Holding History

Janus Henderson Group’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-33,963
Closed -$72.2K – 2572
2023
Q3 		$72.2K Buy
33,963
+9
+0% +$30 ﹤0.01% 2539
2023
Q2 		$161K Buy
33,954
+16
+0% +$88 ﹤0.01% 2503
2023
Q1 		$194K Buy
33,938
+18,519
+120% +$112K ﹤0.01% 2502
2022
Q4 		$156K Sell
15,419
-1,409,307
-99% -$26.5M ﹤0.01% 2245
2022
Q3 		$31.9M Sell
1,424,726
-10,787
-0.8% -$312K 0.02% 464
2022
Q2 		$35.6M Sell
1,435,513
-33,887
-2% -$935K 0.02% 456
2022
Q1 		$57M Sell
1,469,400
-73,204
-5% -$2.83M 0.03% 459
2021
Q4 		$90.3M Sell
1,542,604
-179,207
-10% -$10.2M 0.04% 376
2021
Q3 		$102M Sell
1,721,811
-104,173
-6% -$8.17M 0.04% 360
2021
Q2 		$158M Sell
1,825,984
-74,648
-4% -$6.02M 0.07% 282
2021
Q1 		$157M Sell
1,900,632
-644,936
-25% -$61.8M 0.07% 269
2020
Q4 		$231M Sell
2,545,568
-621,141
-20% -$38.6M 0.11% 197
2020
Q3 		$127M Sell
3,166,709
-492,685
-13% -$17.2M 0.07% 284
2020
Q2 		$126M Buy
3,659,394
+363,775
+11% +$10.8M 0.07% 271
2020
Q1 		$73.2M Buy
3,295,619
+3,285,567
+32,686% +$83.1M 0.05% 354
2019
Q4 		$197K Buy
+10,052
New +$160K ﹤0.01% 1394

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Janus Henderson Group's FATE Position: Q4 2023 in Review

Janus Henderson Group sold out of Fate Therapeutics (FATE) in Q4 2023, closing a stake of 33,963 shares — an estimated $72.2K sold.

Janus Henderson Group first reported a position in FATE in Q4 2019 and held it in 16 quarters. The position peaked at $231M in Q4 2020. 159 funds tracked by Wall St. Rank hold FATE as of Q4 2023.

  • Janus Henderson Group reported no remaining Fate Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Janus Henderson Group sold 33,963 Fate Therapeutics shares in Q4 2023, an estimated $72.2K.
  • Janus Henderson Group first reported a position in Fate Therapeutics in Q4 2019 and held it in 16 quarters.
  • Janus Henderson Group's Fate Therapeutics position peaked at $231M in Q4 2020.
  • 159 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2023.

Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.